The US FDA has approved a new non-opioid painkiller, Journavx, by Vertex Pharmaceuticals, which targets pain signals before reaching the brain to provide relief for moderate to severe pain without the addictive potential of opioids. Clinical trials showed effectiveness in reducing post-surgery pain, marking an important milestone in acute pain management amidst the opioid crisis in the US. Priced at $15.50 per capsule, Journavx is the first new class of pain medicine approved in over 20 years, offering hope for the 80 million Americans prescribed pain medication annually.
Full Article
Court suspends Thailand’s PM pending case over leaked phone call | Politics News
A Thai court has accepted a petition from senators that accuse the PM of dishonesty and breaching ethical standards.Thailand’s Constitutional Court has suspended Prime Minister Paetongtarn Shinawatra amid an ethics investigation over a leaked phone call with former Cambodian leader Hun Sen, as domestic outrage grows and her coalition shrinks. The Pheu Thai Party faces declining support, with Paetongtarn's approval rating dropping significantly, while her father, Thaksin, confronts legal challenges as well. Explain It To...
Read more